Literature DB >> 2891353

Glycolipid anchors are attached to Thy-1 glycoprotein rapidly after translation.

A Conzelmann1, A Spiazzi, C Bron.   

Abstract

The attachment of glycolipid anchors to the Thy-1 glycoprotein during biosynthesis was followed by the change of detergent-binding properties of biosynthetically labelled Thy-1 precursors upon phospholipase C treatment in the murine thymoma lines BW5147 and S1A. In S1A, 80% of the Thy-1 molecules were phospholipase-C-sensitive after a 2 min pulse with [35S]methionine, indicating that these molecules were already anchored via a glycolipid tail. In BW5147, 47% of the Thy-1 molecules had phospholipase-C-sensitive anchors attached after a 1.5 min labelling and, with longer pulses, this percentage rose to 76%. Tunicamycin did not block the addition of glycolipid anchors, and glycolipid attachment also occurred at 21 degrees C. The findings suggest that the attachment of glycolipid anchors occurs in the rough endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891353      PMCID: PMC1148323          DOI: 10.1042/bj2460605

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Specific release of plasma membrane enzymes by a phosphatidylinositol-specific phospholipase C.

Authors:  M G Low; J B Finean
Journal:  Biochim Biophys Acta       Date:  1978-04-20

2.  Non-lytic release of acetylcholinesterase from erythrocytes by a phosphatidylinositol-specific phospholipase C.

Authors:  M G Low; J B Finean
Journal:  FEBS Lett       Date:  1977-10-01       Impact factor: 4.124

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Release of alkaline phosphatase from membranes by a phosphatidylinositol-specific phospholipase C.

Authors:  M G Low; J B Finean
Journal:  Biochem J       Date:  1977-10-01       Impact factor: 3.857

5.  Phosphatidyl inositol-specific phospholipase C from Clostridium novyi type A.

Authors:  R Taguchi; H Ikezawa
Journal:  Arch Biochem Biophys       Date:  1978-02       Impact factor: 4.013

6.  The primary glycosylation defect in class E Thy-1-negative mutant mouse lymphoma cells is an inability to synthesize dolichol-P-mannose.

Authors:  A Chapman; K Fujimoto; S Kornfeld
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

7.  Production and characterization of monoclonal anti-Thy-1 antibodies that stimulate lymphokine production by cytolytic T cell clones.

Authors:  H R MacDonald; C Bron; M Rousseaux; C Horvath; J C Cerottini
Journal:  Eur J Immunol       Date:  1985-05       Impact factor: 5.532

8.  Studies on phosphatidylinositol phosphodiesterase (phospholipase C type) of Bacillus cereus. I. purification, properties and phosphatase-releasing activity.

Authors:  H Ikezawa; M Yamanegi; R Taguchi; T Miyashita; T Ohyabu
Journal:  Biochim Biophys Acta       Date:  1976-11-19

9.  The synthesis and properties of T25 blycoprotein in Thy-1-negative mutant lymphoma cells.

Authors:  I S Trowbridge; R Hyman; C Mazauskas
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

10.  Expression of Thy-1 glycoprotein on lectin-resistant lymphoma cell lines.

Authors:  I S Trowbridge; R Hyman; T Ferson; C Mazauskas
Journal:  Eur J Immunol       Date:  1978-10       Impact factor: 5.532

View more
  19 in total

Review 1.  [Paroxysmal nocturnal hemoglobinuria].

Authors:  P Blaas; S Weber; G M Hänsch; H H Peter
Journal:  Klin Wochenschr       Date:  1990-03-05

Review 2.  Emerging functional roles for the glycosyl-phosphatidylinositol membrane protein anchor.

Authors:  M P Lisanti; E Rodriguez-Boulan; A R Saltiel
Journal:  J Membr Biol       Date:  1990-07       Impact factor: 1.843

3.  Oligomerization of glycolipid-anchored and soluble forms of the vesicular stomatitis virus glycoprotein.

Authors:  B Crise; A Ruusala; P Zagouras; A Shaw; J K Rose
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

4.  No glycolipid anchors are added to Thy-1 glycoprotein in Thy-1-negative mutant thymoma cells of four different complementation classes.

Authors:  A Conzelmann; A Spiazzi; C Bron; R Hyman
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

5.  Atypical mannolipids characterize Thy-1-negative lymphoma mutants.

Authors:  P Lemansky; D K Gupta; S Meyale; G Tucker; A M Tartakoff
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

6.  In vitro attachment of glycosyl-inositolphospholipid anchor structures to mouse Thy-1 antigen and human decay-accelerating factor.

Authors:  N Fasel; M Rousseaux; E Schaerer; M E Medof; M L Tykocinski; C Bron
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Biosynthesis of glycosylphosphatidylinositol-anchored human placental alkaline phosphatase: evidence for a phospholipase C-sensitive precursor and its post-attachment conversion into a phospholipase C-resistant form.

Authors:  Y W Wong; M G Low
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

8.  Glycosylation of Asn-76 in mouse GPIHBP1 is critical for its appearance on the cell surface and the binding of chylomicrons and lipoprotein lipase.

Authors:  Anne P Beigneux; Peter Gin; Brandon S J Davies; Michael M Weinstein; André Bensadoun; Robert O Ryan; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2008-03-13       Impact factor: 5.922

9.  Expression of an enzymically active glycosylphosphatidylinositol-anchored form of neutral endopeptidase (EC 3.4.24.11) in Cos-1 cells.

Authors:  S Howell; C Lanctôt; G Boileau; P Crine
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

10.  Phosphatidylinositol-glycan (PI-G)-anchored membrane proteins: requirement of ATP and GTP for translation-independent COOH-terminal processing.

Authors:  R Amthauer; K Kodukula; L Brink; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.